Fludarabine

T-Cell Large Granular Lymphocyte Leukemia

Ohio State University Comprehensive Cancer CenterSmall moleculePhase 2Dormant

BBB

76/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 64/ 100
Competitive Position: 95/ 100

Competitive context

7 Active assets in the T-Cell Large Granular Lymphocyte Leukemia cohort.

Asset / Sponsor	Phase	Rating
Cyclosporin A Case Comprehensive Cancer Center	Phase 2	BB
Cyclophosphamide Case Comprehensive Cancer Center	Phase 2	BB
BUSULFANUM Ohio State University Comprehensive Cancer Center	Phase 2	BB
Rituximab Northwestern University	Phase 2	B
Cediranib Morphotek	Phase 2	B

View all 47 →

Same molecule, other indications

Fludarabine is also rated in:

adult T-cell leukemia/lymphomaActive

BBB

Indicative · Phase 2

76 / 100

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant

BBB

Indicative · Phase 2

76 / 100

Fanconi anemiaActive

BBB

Indicative · Phase 2/3

76 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.